DualityBio-B Completes Regulatory Guidance Phase for Planned Shanghai STAR Market Listing

Stock News06-10

The biotechnology firm DUALITYBIO-B (09606) has issued a formal announcement regarding its progress towards a proposed listing.

The company is currently undergoing the preparatory guidance process for a potential initial public offering of ordinary shares, which would be listed and traded in Renminbi on the Shanghai Stock Exchange's Science and Technology Innovation Board, commonly known as the STAR Market.

The preparatory guidance is being conducted by China Securities Co., Ltd., and the company has now successfully passed the acceptance review for this process conducted by the Shanghai Bureau of the China Securities Regulatory Commission.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1149238784?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-10 06:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1149238784","market":"sh","top_or_hot":-1,"title":"DualityBio-B Completes Regulatory Guidance Phase for Planned Shanghai STAR Market Listing","media":"Stock News","content":"<p>The biotechnology firm <b>DUALITYBIO-B</b> (<b>09606</b>) has issued a formal announcement regarding its progress towards a proposed listing.<br><br>The company is currently undergoing the preparatory guidance process for a potential initial public offering of ordinary shares, which would be listed and traded in Renminbi on the Shanghai Stock Exchange's Science and Technology Innovation Board, commonly known as the STAR Market.<br><br>The preparatory guidance is being conducted by China Securities Co., Ltd., and the company has now successfully passed the acceptance review for this process conducted by the Shanghai Bureau of the China Securities Regulatory Commission.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>DualityBio-B Completes Regulatory Guidance Phase for Planned Shanghai STAR Market Listing</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDualityBio-B Completes Regulatory Guidance Phase for Planned Shanghai STAR Market Listing\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-06-10 06:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>The biotechnology firm <b>DUALITYBIO-B</b> (<b>09606</b>) has issued a formal announcement regarding its progress towards a proposed listing.<br><br>The company is currently undergoing the preparatory guidance process for a potential initial public offering of ordinary shares, which would be listed and traded in Renminbi on the Shanghai Stock Exchange's Science and Technology Innovation Board, commonly known as the STAR Market.<br><br>The preparatory guidance is being conducted by China Securities Co., Ltd., and the company has now successfully passed the acceptance review for this process conducted by the Shanghai Bureau of the China Securities Regulatory Commission.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"FT_SY_CNH","symbol_name":"HK人民币","start_time":0,"source_url":"","article_id":"1149238784","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1149238784","pubTimestamp":1781044335,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"The biotechnology firm DUALITYBIO-B (09606) has issued a formal announcement regarding its progress towards a proposed listing.The company is currently undergoing the preparatory guidance process for...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"159982":"中证500","CYB":"人民币ETF-WisdomTree Dreyfus","HK0000252160.HKD":"易方达 (香港) 中国股票股息基金A 类 (分派) 港元","BK1161":"生物科技","LU2543165471.USD":"E FUND (HK) GLOBAL QUALITY GROWTH \"A\" (USD) ACC","09606":"映恩生物-B","IPOS":"Renaissance International IPO ETF","HK0000500386.USD":"易方达 (香港) 中国股票股息基金A 类 (累积) 美元","HK0000252152.HKD":"易方达 (香港) 中国股票股息基金A 类 (累积) 港元"},"translate_title":"DualityBio-B完成上海科创板上市的监管指导阶段","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159982":1,"CNHmain":1,"UCmain":1,"MUCmain":1,"09606":1,"MCNHmain":1,"IPOS":1,"CYB":1},"content_text":"The biotechnology firm DUALITYBIO-B (09606) has issued a formal announcement regarding its progress towards a proposed listing.The company is currently undergoing the preparatory guidance process for a potential initial public offering of ordinary shares, which would be listed and traded in Renminbi on the Shanghai Stock Exchange's Science and Technology Innovation Board, commonly known as the STAR Market.The preparatory guidance is being conducted by China Securities Co., Ltd., and the company has now successfully passed the acceptance review for this process conducted by the Shanghai Bureau of the China Securities Regulatory Commission.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1149238784","isCrawlerRequest":true}